Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Randomized multicenter single-blind controlled trial on ozonated blood in COVID-19 severe pneumonia
2020-005020-11Phase 2Active
- Sponsor
- Policlínica Nuestra Señora del Rosario
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, single-blind trial of medical ozonated water in coronavirus pneumonia (2 arms), sponsored by Policlínica Nuestra Señora del Rosario. Primary endpoint: Clinical improvement at day 28. Started Feb 2021; status: active.
02
Drugs
medical ozonated water
03
Conditions
coronavirus pneumonia
Beyond the preview
Go deeper on 2020-005020-11.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2020-005020-11.